54 / 58
Pharmacological inhibition of BTK (ibrutinib) in PDAC can reactivate adaptive
immune responses.
Gunderson et al, Cancer discov 2016
Stromal –associated
fibtroblast recruits
B regs
(produces TP), may
be inhibited by BTK
inhibitors, such
ibrutinib